EGFR and neoplasm: Martirosyan et al. (109) reported the use of an FITC-conjugated anti-EGFR antibody (~70,000 Da) for the identification of EGFR-expressing F98 tumor cells using confocal laser endomicroscopy in rats 24 h after IV administration of the FITC-conjugated antibodies.